MGMT and central nervous system cancer: Besides monitoring the CSF exosomal miR-21 levels in glioma patients, a list of well-known prognostic glioma-related markers, including levels of Ki-67, EGFR, PTEN, mutant P53, and methylation of the MGMT promoter were worthwhile to be analyses for correlation studies.